Company Filing History:
Years Active: 2017
Title: Veronique Mary: Innovator in Alzheimer's Disease Treatment
Introduction
Veronique Mary is a prominent inventor based in Evry, France. She has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of Alzheimer's disease. Her innovative work has led to the development of a unique patent that addresses critical challenges in this area.
Latest Patents
Veronique Mary holds a patent for an H3 receptor antagonist aimed at treating Alzheimer's disease. This patent, which is titled "H3 receptor antagonist for use in the treatment of Alzheimer's disease," relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in disease-modifying therapy for Alzheimer's disease, other tauopathies, and related neurodegenerative diseases. This innovative approach has the potential to significantly impact the treatment landscape for these conditions.
Career Highlights
Veronique Mary is associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to collaborate with other talented professionals in the field, contributing to advancements in medical research and drug development.
Collaborations
Some of her notable coworkers include Pascal Barneoud and Veronique Blanchard-Bregeon. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Veronique Mary is a trailblazer in the field of Alzheimer's disease treatment, with her innovative patent showcasing her commitment to addressing complex medical challenges. Her contributions are paving the way for future advancements in neurodegenerative disease therapies.